METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis
NYSE:MTD - New York Stock Exchange, Inc. - US5926881054 - Common Stock - Currency: USD
Overall MTD gets a fundamental rating of 5 out of 10. We evaluated MTD against 56 industry peers in the Life Sciences Tools & Services industry. MTD has an excellent profitability rating, but there are some minor concerns on its financial health. MTD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
MTD had positive earnings in the past year.
In the past year MTD had a positive cash flow from operations.
MTD had positive earnings in each of the past 5 years.
Each year in the past 5 years MTD had a positive operating cash flow.
1.2 Ratios
MTD has a Return On Assets of 26.25%. This is amongst the best in the industry. MTD outperforms 100.00% of its industry peers.
The Return On Invested Capital of MTD (43.51%) is better than 96.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MTD is significantly above the industry average of 13.15%.
The last Return On Invested Capital (43.51%) for MTD is above the 3 year average (41.86%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.25% | ||
| ROE | N/A | ||
| ROIC | 43.51% |
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
1.3 Margins
The Profit Margin of MTD (22.17%) is better than 100.00% of its industry peers.
In the last couple of years the Profit Margin of MTD has grown nicely.
The Operating Margin of MTD (28.85%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of MTD has grown nicely.
MTD has a Gross Margin of 60.14%. This is amongst the best in the industry. MTD outperforms 80.36% of its industry peers.
In the last couple of years the Gross Margin of MTD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.85% | ||
| PM (TTM) | 22.17% | ||
| GM | 60.14% |
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
MTD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MTD has been reduced compared to 1 year ago.
The number of shares outstanding for MTD has been reduced compared to 5 years ago.
Compared to 1 year ago, MTD has a worse debt to assets ratio.
2.2 Solvency
MTD has an Altman-Z score of 10.41. This indicates that MTD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MTD (10.41) is better than 94.64% of its industry peers.
MTD has a debt to FCF ratio of 2.39. This is a good value and a sign of high solvency as MTD would need 2.39 years to pay back of all of its debts.
MTD's Debt to FCF ratio of 2.39 is amongst the best of the industry. MTD outperforms 82.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.39 | ||
| Altman-Z | 10.41 |
ROIC/WACC4.2
WACC10.37%
2.3 Liquidity
MTD has a Current Ratio of 1.01. This is a normal value and indicates that MTD is financially healthy and should not expect problems in meeting its short term obligations.
MTD's Current ratio of 1.01 is on the low side compared to the rest of the industry. MTD is outperformed by 83.93% of its industry peers.
A Quick Ratio of 0.70 indicates that MTD may have some problems paying its short term obligations.
MTD has a worse Quick ratio (0.70) than 91.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.69% over the past year.
Measured over the past years, MTD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.53% on average per year.
The Revenue has been growing slightly by 1.18% in the past year.
Measured over the past years, MTD shows a small growth in Revenue. The Revenue has been growing by 5.18% on average per year.
EPS 1Y (TTM)5.69%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%-7.87%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%-4.56%
3.2 Future
Based on estimates for the next years, MTD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.32% on average per year.
Based on estimates for the next years, MTD will show a small growth in Revenue. The Revenue will grow by 3.81% on average per year.
EPS Next Y2.01%
EPS Next 2Y6.19%
EPS Next 3Y7.97%
EPS Next 5Y9.32%
Revenue Next Year2.24%
Revenue Next 2Y3.41%
Revenue Next 3Y4.01%
Revenue Next 5Y3.81%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 29.53, MTD can be considered very expensive at the moment.
Based on the Price/Earnings ratio, MTD is valued a bit cheaper than 64.29% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.48, MTD is valued at the same level.
MTD is valuated quite expensively with a Price/Forward Earnings ratio of 25.74.
Based on the Price/Forward Earnings ratio, MTD is valued a bit cheaper than the industry average as 69.64% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.52. MTD is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.53 | ||
| Fwd PE | 25.74 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MTD is valued a bit cheaper than the industry average as 69.64% of the companies are valued more expensively.
67.86% of the companies in the same industry are more expensive than MTD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.57 | ||
| EV/EBITDA | 22.06 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTD does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MTD may justify a higher PE ratio.
PEG (NY)14.69
PEG (5Y)2.36
EPS Next 2Y6.19%
EPS Next 3Y7.97%
5. Dividend
5.1 Amount
No dividends for MTD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1194.85
-10.83 (-0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.55%
Inst Owner Change0%
Ins Owners0.42%
Ins Owner Change1.1%
Market Cap24.83B
Analysts71.58
Price Target1281.74 (7.27%)
Short Float %3.01%
Short Ratio3.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.86%
Min EPS beat(2)2.78%
Max EPS beat(2)4.94%
EPS beat(4)4
Avg EPS beat(4)3.62%
Min EPS beat(4)1.02%
Max EPS beat(4)5.75%
EPS beat(8)6
Avg EPS beat(8)2.82%
EPS beat(12)10
Avg EPS beat(12)2.83%
EPS beat(16)14
Avg EPS beat(16)3.44%
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-0.18%
Max Revenue beat(2)2.56%
Revenue beat(4)3
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.56%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)0.26%
Revenue beat(16)12
Avg Revenue beat(16)0.79%
PT rev (1m)-0.23%
PT rev (3m)-10%
EPS NQ rev (1m)0.53%
EPS NQ rev (3m)-5.91%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)-0.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.53 | ||
| Fwd PE | 25.74 | ||
| P/S | 6.48 | ||
| P/FCF | 28.57 | ||
| P/OCF | 25.52 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 22.06 |
EPS(TTM)40.46
EY3.39%
EPS(NY)46.42
Fwd EY3.88%
FCF(TTM)41.82
FCFY3.5%
OCF(TTM)46.81
OCFY3.92%
SpS184.32
BVpS-8.76
TBVpS-53.27
PEG (NY)14.69
PEG (5Y)2.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.25% | ||
| ROE | N/A | ||
| ROCE | 52.99% | ||
| ROIC | 43.51% | ||
| ROICexc | 44.9% | ||
| ROICexgc | 82.8% | ||
| OM | 28.85% | ||
| PM (TTM) | 22.17% | ||
| GM | 60.14% | ||
| FCFM | 22.69% |
ROA(3y)25.04%
ROA(5y)23.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.86%
ROIC(5y)39.3%
ROICexc(3y)43.32%
ROICexc(5y)40.86%
ROICexgc(3y)78.59%
ROICexgc(5y)73.33%
ROCE(3y)50.98%
ROCE(5y)47.86%
ROICexcg growth 3Y5.41%
ROICexcg growth 5Y8.89%
ROICexc growth 3Y5.36%
ROICexc growth 5Y6.84%
OM growth 3Y2.77%
OM growth 5Y3.56%
PM growth 3Y2.52%
PM growth 5Y3.63%
GM growth 3Y0.93%
GM growth 5Y0.74%
F-Score7
Asset Turnover1.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.39 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 84.96% | ||
| Cap/Sales | 2.71% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.29% | ||
| Profit Quality | 102.34% | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 10.41 |
F-Score7
WACC10.37%
ROIC/WACC4.2
Cap/Depr(3y)92.83%
Cap/Depr(5y)94.35%
Cap/Sales(3y)2.85%
Cap/Sales(5y)2.89%
Profit Quality(3y)97.94%
Profit Quality(5y)100.58%
High Growth Momentum
Growth
EPS 1Y (TTM)5.69%
EPS 3Y6.67%
EPS 5Y12.53%
EPS Q2Q%-7.87%
EPS Next Y2.01%
EPS Next 2Y6.19%
EPS Next 3Y7.97%
EPS Next 5Y9.32%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y1.37%
Revenue growth 5Y5.18%
Sales Q2Q%-4.56%
Revenue Next Year2.24%
Revenue Next 2Y3.41%
Revenue Next 3Y4.01%
Revenue Next 5Y3.81%
EBIT growth 1Y1.9%
EBIT growth 3Y4.18%
EBIT growth 5Y8.92%
EBIT Next Year5.6%
EBIT Next 3Y6.42%
EBIT Next 5Y7.26%
FCF growth 1Y9.12%
FCF growth 3Y2.57%
FCF growth 5Y11.3%
OCF growth 1Y5.56%
OCF growth 3Y2.14%
OCF growth 5Y9.92%